A woman’s test result is a good indication that she has breast or ovarian cancer, but not a clear indication of whether she has the disease, a new study finds.
The findings may help doctors decide whether to treat the woman with an aggressive surgical intervention to remove the cancerous tissue or wait for a full diagnostic test, researchers said.
The results come from a study that followed more than 7,000 women diagnosed with breast cancer in the United States between 1999 and 2007.
In this picture taken from video, a woman with breast or other cancer waits for a test at a hospital in New York.
This image shows a woman who was diagnosed with the disease at a cancer clinic in Atlanta.
The women in the study were followed for two years.
Breast cancer is a rare disease that affects only a few women in each state, and it has a relatively short survival time.
The risk of dying from the disease is about 20 percent, according to the American Cancer Society.
But the cancer is very aggressive, and a woman’s chance of surviving an attack increases dramatically, according the study.
If a woman develops symptoms of breast cancer before she is 70, the odds of survival is 10 times higher than if she has never developed the disease.
But if she develops symptoms during her lifetime, the risk is three to six times higher, researchers wrote.
The new study is published online this week in the Journal of the American Medical Association.
The study used data from the National Health and Nutrition Examination Survey, which asked women about symptoms of the disease over the past year.
The researchers asked the women to report any signs of the cancer, including the number of days they had symptoms, their age, and whether they had breast cancer.
Women who reported symptoms during their lifetime were also asked about the number and types of treatments they had received over the years.
About 4 percent of women in this study had been diagnosed with cancer.
The remaining 6 percent had never had the disease and had never been diagnosed, according a news release from the study authors.
Those women were excluded from the analysis because they had been excluded from previous studies.
The data did not include other types of symptoms, such as nausea, fatigue, dizziness, or anxiety.
However, the women who had breast or prostate cancer symptoms were significantly more likely to have undergone an aggressive medical treatment than those without any symptoms.
The patients with breast and prostate cancer were more likely than those who had no symptoms to have experienced an abnormal test result.
The test results were compared to other information about breast and other cancers, such to whether the cancer was on the breast or on the prostate.
The participants were also given a list of symptoms that included “excessive bleeding, chest pain, or discomfort in the chest,” “pain, swelling, or tenderness in the skin around the nipple,” and “nausea, vomiting, or abdominal pain.”
The women with breast, prostate, or other cancers were also more likely if they had ever been hospitalized or if they were taking chemotherapy.
In the study, the researchers found that people with the most symptoms were also those who were diagnosed with more advanced cancer, and they also had more of the same cancers on the chest.
The number of tests done during the study was also linked to how much the cancer progressed, the results showed.
People who had symptoms during the past 12 months had a 25 percent increased risk of developing the disease compared to people with no symptoms.
This is an important finding because it suggests that the breast cancer patients who have the most tests should be monitored more closely, said study author Dr. David G. Schuman, of Emory University.
In addition, people who had more tests in the past month were also at increased risk for developing the cancer.
In a follow-up analysis, the authors also compared the number, type, and type of tests they had done to the number the cancer had on the mammary glands, which could be a clue about their risk of the cancers spreading.
The group of women who tested positive for the disease had more than doubled the risk of their cancer spreading, compared to women who did not test positive, Schuman said.
“It appears that breast cancer is not only a common and treatable disease, but it is a very aggressive disease,” Schuman told MedPage Today.
The authors also found that women who were treated for breast cancer had a higher risk of survival than those not treated.
People treated for cancer are at risk for death, but survival is also affected, according Schuman.
He added that some people may be able to avoid getting cancer by getting treatment.
“Patients who are not treated for this disease have a greater risk of death than those treated,” Schumann said.
Women with cancer are more likely not to be treated for it, but they also may have higher levels of the enzyme prostaglandin E2 (PGE2), which can help reduce the amount of cancer cells that the body makes, according Toews. The cancer